Sir -In their recent paper on their follow-up (cohort) study of 60,065 newly diagnosed breast cancer patients, Adami et al. (1987) reported that 260 endometrial cancers had been diagnosed after the breast cancer diagnosis compared to an expected number, based on national rates, of 151.1 (relative risk= 260/151.1 = 1.72). This relative risk for the subsequent incidence of endometrial cancer in breast cancer patients increased from 0.95 in patients diagnosed with breast cancer before age 40 to 2.47 in patients diagnosed at 80 years of age or older. The authors go on from this to state that 'there is no obvious common risk factor related to reproductive life which could give a reasonable explanation for [this observed] age-dependent association between cancer of the breast and cancer of the endometrium', and imply that this age dependence is evidence against the 'traditional... paradigm' of seeking the causes of (and link between) these two cancers in terms of ' (Siiteri, 1978; Nisker et al., 1980; Henderson et al., 1982) .
Late age at first birth, late age at menopause and use of ERT all increase the risk of breast cancer (Thomas, 1984; Pike & Ross, 1984 (McPherson & Drife, 1986) . The sharp distinction between the protective effect of COC use against endometrial cancer and the lack of any such effect on breast cancer risk clearly shows that the endocrinology of endometrial cancer and breast cancer are not the same. Most important for an understanding of the results of Adami et al. (1987) is the finding that obesity is only associated with an increased risk of breast cancer in older post-menopausal women (Kelsey et al., 1981; Lubin et al., 1985) . In pre-menopausal women obesity has been found, in fact, to be associated with a decreased risk of breast cancer (Willett et al., 1985) .
In the pre-menopausal period obesity acts contrariwise as a risk factor in endometrial cancer and breast cancer. Premenopausal breast cancer patients will tend to be of low parity but non-obese, so that their risk of endometrial cancer will probably be little different from expected as their low parity will slightly increase their risk while their non-obesity A letter in similar vein to that of Key and Pike has also been received from Dr F. de Waard, Dept. of Epidemiology, Rijsinstituut voor Volksgezondheid en Milieuhygiene, The Netherlands.
will decrease it. Post-menopausal breast cancer patients will tend to be of low parity and of late menopause, and to be obese: their risk of endometrial cancer will be increased (relative to expected) on all counts. The association of breast cancer with obesity only becomes clear five to ten years after menopause (Kelsey et al., 1981; Lubin et al., 1985) when the protective effect evident in the pre-menopausal period has had time to be reversed, so that the greatly increased risk of endometrial cancer associated with obesity will become evident only in older post-menopausal breast cancer patients. This is precisely what Adami et al. (1987) attractive goal to find unifying concepts which link, for example, hormonal derivatives of risk factors to the probability of development of the disease. Most hypotheses related to such attempts have the postulate in common that excess oestrogenic stimulation -for example due to high circulating levels or increased bioavailability of oestrogens or insufficient opposing effects of progesteroneis an important determinant for neoplastic transformation, particularly if occurring during periods of assumed increased susceptibility of the target organ.
We agree with Key and Pike that the findings concerning relations to cancer of the endometrium have been fairly consistent. However, as far as breast cancer is concerned, the pattern is frustratingly complex and equivocal. A scrutiny of available data has shown that the number of studies in which the association between breast cancer and the 'established risk factors' (e.g. early menarche, low parity, late first birth, late menopause, short duration of breast feeding) has been found to be weak or absent is greater than can be explained by methodological flaws and type II errors. The resulting uncertainty might be an important reason why the same factors are actually being studied over and over again. The lack of association between age at first birth and risk of breast cancer, which we found at the beginning of this decade (Adami et al., 1980 ) has now been confirmed in Denmark (Ewertz, 1987) , Norway (Kvale et al., 1987) and Sweden (Adami, unpublished) .
It is an attractive challenge to attempt to reduce this confusing pattern to a single unifying hypothesis. The risk involved in this approach is that when the same risk factors are selected and approximately the same hypothesis formulated a number of times, a conformistic situation is created in which the large inconsistencies in available evidence become neglected. This will hamper a critical assessment of current research strategies and delay the advancement of more fruitful hypotheses. More specifically, the 'general understanding' to which Key and Pike refer, requires that obesity be a risk factor for postmenopausal breast cancer -and preferably that it protect against premenopausal occurrence in the Swedish population. We agree that our previous entirely negative finding in a relatively small case control study needs to be confirmed (Adami et al., 1977) . Confirmatory results to be published have emerged, however, from two other sets of data. Thus, a recent case-control study in women younger than 45 years (Meirik et al., 1986) failed to reveal any association between obesity and breast cancer (unpublished). Likewise, weight was analysed in a nested case-control study within a cohort of women who had received climacteric oestrogen treatment (Persson et al., 1983; Bergkvist, 1987) . Using weight below 60 kg as a reference, the relative risk in women who weighed 90 kg or more was 0.55 (95% confidence interval 0.15-2.00). When weight was included as a continuous variable in a logistic regression model, the relative risk per kg increase was 0.99 (0.98-1.02) (Bergkvist, unpublished) . These findings are not unique for the Swedish population. The literature offers in fact only highly equivocal support for the finding that is crucial for the claim by Key and Pike, namely that obesity entails an increased risk of developing breast cancer. And in the positive reports, the possible confounding effect of dietary patterns needs to be clarified.
From these considerations, we still believe that critical judgement of available evidence justifies the conclusion that the common aetiological mechanisms of breast and endometrial cancer are poorly understood within the general framework ('the traditional paradigm') of associations with obesity, the reproductive characteristics and exogenous hormones. 
